# A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol

**Authors:** Franz Förster, Katrin Horn, Janne Pott, Graciela E. Delgado, Marcus E. Kleber, Winfried März, Angela Patricia Moissl-Blanke, Günther Silbernagel, Melanie Waldenberger, Harald Grallert, Annette Peters, Christian Gieger, Ronny Baber, Holger Kirsten, Markus Loeffler, Berend Isermann, Joachim Thiery, Peter Kovacs, Anke Tönjes, Michael Stumvoll, Helena Gylling, Mika Kähönen, Terho Lehtimäki, Pashupati Prasad Mishra, Olli Raitakari, Uta Ceglarek, Markus Scholz

PMC · DOI: 10.1016/j.ebiom.2026.106144 · eBioMedicine · 2026-01-30

## TL;DR

This study identifies new genetic links to cholesterol precursors, showing lanosterol's indirect role in heart disease.

## Contribution

The study reports four new genome-wide significant associations for cholesterol synthesis intermediates, including two novel loci.

## Key findings

- Four genome-wide significant associations were found, including two novel loci for lanosterol and free cholesterol.
- Lanosterol showed significant total and indirect effects on coronary artery disease, but no direct effect.
- Eight previously reported cholesterol-related loci were replicated in this analysis.

## Abstract

Cholesterol is a main contributor to coronary artery disease (CAD). Although the genetic basis of blood cholesterol concentration is well studied, there is currently a lack of studies investigating the genetics of its precursors from de novo biosynthesis.

We conducted a genome-wide association meta-analysis, combining data from KORA, LIFE-Heart, LIFE-Adult, LURIC, the Sorbs study, and YFS, resulting in up to 10,519 individuals. We investigated 14 traits related to serum concentrations of lanosterol, desmosterol, and cholesterol. Direct and indirect effects of lanosterol on CAD were investigated with a Mendelian randomisation mediation analysis.

Our analysis revealed four genome-wide significant (p < 5 × 10−8) associations not previously reported in the GWAS catalogue. These include two loci without prior connection to cholesterol, associated with lanosterol (7q21.2, CYP51A1) and free cholesterol (11q14.1), and two associations with lanosterol at loci previously reported for cholesterol (5q13.3, HMGCR; 11q23.3, APO cluster). We also replicated eight loci previously reported for associations with cholesterol-related traits. Lanosterol exhibited significant total and indirect effects on CAD, but its direct effect was not significant.

We demonstrate that the investigation of intermediate phenotypes can help to functionally fine map previously reported associations for cholesterol, improving our understanding of genetic regulation of cholesterol concentrations. Further, the effect of lanosterol on CAD is probably fully mediated by total cholesterol.

This investigation was primarily funded by the ministry for science and health of the Rhineland-Palatinate through the CoAGE graduate programme. A complete list of funding organisations is provided in the acknowledgements.

## Linked entities

- **Genes:** CYP51A1 (cytochrome P450 family 51 subfamily A member 1) [NCBI Gene 1595], HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156], AOPEP (aminopeptidase O (putative)) [NCBI Gene 84909]
- **Chemicals:** lanosterol (PubChem CID 246983), desmosterol (PubChem CID 439577), cholesterol (PubChem CID 5997)
- **Diseases:** coronary artery disease (MONDO:0005010)

## Full-text entities

- **Genes:** SOAT1 (sterol O-acyltransferase 1) [NCBI Gene 6646] {aka ACACT, ACAT, ACAT-1, ACAT1, SOAT, STAT}, APOA4 (apolipoprotein A4) [NCBI Gene 337] {aka ADTKD6}, ABCA1 (ATP binding cassette subfamily A member 1) [NCBI Gene 19] {aka ABC-1, ABC1, CERP, HDLCQTL13, HDLDT1, HPALP1}, Lipc (lipase C, hepatic type) [NCBI Gene 15450] {aka HL, Hpl}, APOA5 (apolipoprotein A5) [NCBI Gene 116519] {aka APOAV, RAP3}, LCAT (lecithin-cholesterol acyltransferase) [NCBI Gene 3931], APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, SOAT2 (sterol O-acyltransferase 2) [NCBI Gene 8435] {aka ACACT2, ACAT2, ARGP2}, TRIB1 (tribbles pseudokinase 1) [NCBI Gene 10221] {aka C8FW, GIG-2, GIG2, SKIP1, TRB-1, TRB1}, AKAP9 (A-kinase anchoring protein 9) [NCBI Gene 10142] {aka AKAP-9, AKAP350, AKAP450, CG-NAP, HYPERION, LQT11}, ZPR1 (ZPR1 zinc finger) [NCBI Gene 8882] {aka GKAF, ZNF259}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, APOC1P1 (apolipoprotein C1 pseudogene 1) [NCBI Gene 342] {aka APOC1P, ApoC-IA}, Aldh1a2 (aldehyde dehydrogenase family 1, subfamily A2) [NCBI Gene 19378] {aka Aldh1a7, Raldh1, Raldh2}, CYP51A1 (cytochrome P450 family 51 subfamily A member 1) [NCBI Gene 1595] {aka CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1}, IGKV5-2 (immunoglobulin kappa variable 5-2) [NCBI Gene 28907] {aka B2, IGKV52}, APOC3 (apolipoprotein C3) [NCBI Gene 345] {aka APOCIII, Apo-C3, ApoC-3}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, CS (citrate synthase) [NCBI Gene 1431], DHCR24 (24-dehydrocholesterol reductase) [NCBI Gene 100628197], PSRC1 (proline and serine rich coiled-coil 1) [NCBI Gene 84722] {aka DDA3, FP3214}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, ANGPTL3 (angiopoietin like 3) [NCBI Gene 27329] {aka ANG-5, ANGPT5, ANL3, FHBL2}, AOPEP (aminopeptidase O (putative)) [NCBI Gene 84909] {aka AP-O, APO, C90RF3, C9orf3, DYT31, ONPEP}, Apoc1 (apolipoprotein C-I) [NCBI Gene 11812] {aka Apo-CIB, ApoC-IB, apo-CI, apoC-I}, Tomm40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 53333] {aka Mom35, Tom40}
- **Diseases:** YFS (MESH:C536718), PP (MESH:C536741), CADD (MESH:D019966), atherosclerotic cardiovascular disease (MESH:D050197), CS (MESH:D006223), diabetes (MESH:D003920), coronary heart disease (MESH:D003327), death (MESH:D003643), Cardiovascular Disease (MESH:D002318), CAD (MESH:D003324), CSs (MESH:D020920)
- **Chemicals:** lipid (MESH:D008055), fatty acid (MESH:D005227), lathosterol (MESH:C001521), det (MESH:D003671), brassicasterol (MESH:C003532), esterified cholesterol (MESH:D002788), 14alpha-methyl group (-), phytosterol (MESH:D010840), sterol (MESH:D013261), testosterone (MESH:D013739), desmosterol (MESH:D003897), Lanosterol (MESH:D007810), che (MESH:C050927), mevalonate (MESH:D008798), 7-dehydrocholesterol (MESH:C016705), steroid hormones (MESH:D013256), campesterol (MESH:C021273), Cholesterol (MESH:D002784), bile acid (MESH:D001647), triglyceride (MESH:D014280), vitamin D (MESH:D014807), def (MESH:C006863), retinoic acid (MESH:D014212), beta-sitosterol (MESH:C025473)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Rs2299239, rs12916, rs17629703, rs7528419, rs588136, Rs2043082, rs11279109, rs7412, rs190126802, rs10038095, rs429358, Rs59007384, rs2954032, rs4149307, rs964184, rs11208009, rs6465351, rs6511720

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876664/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12876664/full.md

## References

99 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876664/full.md

---
Source: https://tomesphere.com/paper/PMC12876664